Journal of Clinical Virology
Volume 47, Issue 1 , Pages 23-28 , January 2010

Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008–2009 season

  • Tatiana Baranovich

      Affiliations

    • Division of Public Health, Department of Infectious Disease Control and International Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757, Asahimachi-Dori, Chuoku, Niigata City, Niigata Prefecture 951-8510, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 25 227 2129; fax: +81 25 227 0765.
    • ,
  • Reiko Saito

      Affiliations

    • Division of Public Health, Department of Infectious Disease Control and International Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757, Asahimachi-Dori, Chuoku, Niigata City, Niigata Prefecture 951-8510, Japan
    • ,
  • Yasushi Suzuki

      Affiliations

    • Division of Public Health, Department of Infectious Disease Control and International Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757, Asahimachi-Dori, Chuoku, Niigata City, Niigata Prefecture 951-8510, Japan
    • ,
  • Hassan Zaraket

      Affiliations

    • Division of Public Health, Department of Infectious Disease Control and International Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757, Asahimachi-Dori, Chuoku, Niigata City, Niigata Prefecture 951-8510, Japan
    • ,
  • Clyde Dapat

      Affiliations

    • Division of Public Health, Department of Infectious Disease Control and International Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757, Asahimachi-Dori, Chuoku, Niigata City, Niigata Prefecture 951-8510, Japan
    • ,
  • Isolde Caperig-Dapat

      Affiliations

    • Division of Public Health, Department of Infectious Disease Control and International Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757, Asahimachi-Dori, Chuoku, Niigata City, Niigata Prefecture 951-8510, Japan
    • ,
  • Taeko Oguma

      Affiliations

    • Division of Public Health, Department of Infectious Disease Control and International Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757, Asahimachi-Dori, Chuoku, Niigata City, Niigata Prefecture 951-8510, Japan
    • ,
  • Iman Ibrahim Shabana

      Affiliations

    • Division of Public Health, Department of Infectious Disease Control and International Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757, Asahimachi-Dori, Chuoku, Niigata City, Niigata Prefecture 951-8510, Japan
    • ,
  • Takehiko Saito

      Affiliations

    • National Institute of Animal Health, National Agriculture and Food Research Organization, Tsukuba, Ibaraki, Japan
    • ,
  • Hiroshi Suzuki

      Affiliations

    • Division of Public Health, Department of Infectious Disease Control and International Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757, Asahimachi-Dori, Chuoku, Niigata City, Niigata Prefecture 951-8510, Japan
    • ,
  • the Japanese Influenza Collaborative Study Group

      Affiliations

    • Contributing members of the Japanese Influenza Collaborative Study Group are listed in ‘Acknowledgments’ section.

Received 25 August 2009 ,Accepted 4 November 2009.

References 

  1. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med. 2005;353:1363–1373
  2. Sheu T, Deyde V, Okomo-Adhiambo M, et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother. 2008;52:3284–3292
  3. Meijer A, Lackenby A, Hungnes O, et al. Oseltamivir-resistant influenza virus A (H1N1) Europe, 2007–2008 season. Emerg Infect Dis. 2009;15:552–560
  4. Besselaar T, Naidoo D, Buys A, et al. Widespread oseltamivir resistance in influenza A viruses (H1N1) in South Africa. Emerg Infect Dis. 2008;14:1809–1810
  5. Hurt A, Ernest J, Deng Y, et al. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania South East Asia and South Africa. Antiviral Res. 2009;83:90–93
  6. Gubareva L, Kaiser L, Matrosovich M, et al. Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J Infect Dis. 2001;183:523–531
  7. Ives J, Carr J, Mendel D, et al. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res. 2002;55:307–317
  8. Wang M, Tai C, Mendel D. Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivir. Antimicrob Agents Chemother. 2002;46:3809–3816
  9. Abed Y, Goyette N, Boivin G. A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A/H1N1 virus. Antivir Ther. 2004;9:577–581
  10. Tamura D, Mitamura K, Yamazaki M, et al. Oseltamivir-resistant influenza a viruses circulating in Japan. J Clin Microbiol. 2009;47:1424–1427
  11. Pediatric advisory committee briefing document for tamiflu. Tamiflu (RO 64-0796) PAC briefing document; 2008. Available at: http://www.fda.gov/ohrms/dockets/AC/07/briefing/2007-4325b_02_15_Sponsor%20Background%20Package%20Roche.pdf. Accessed 3 August 2009.
  12. Saito R, Li D, Suzuki Y, et al. High prevalence of amantadine-resistance influenza a (H3N2) in six prefectures Japan, in the 2005–2006 season. J Med Virol. 2007;79:1569–1576
  13. Hoffmann E, Stech J, Guan Y, et al. Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol. 2001;146:2275–2289
  14. Esaki H, Noda K, Otsuki N, et al. Rapid detection of quinolone-resistant Salmonella by real time SNP genotyping. J Microbiol Methods. 2004;58:131–134
  15. Masuda H, Suzuki H, Oshitani H, et al. Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan. Microbiol Immunol. 2000;44:833–839
  16. Hurt A, Barr I, Hartel G, et al. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir. Antiviral Res. 2004;62:37–45
  17. Dapat C, Saito R, Kyaw Y, Naito M, Hasegawa G, Suzuki Y, et al. Epidemiology of human influenza A and B viruses in Myanmar from 2005 to 2007. Intervirology. 2009;52:310–320
  18. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987;4:406–425
  19. Kumar S, Tamura K, Nei M. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform. 2004;5:150–163
  20. Varghese J, Colman P. Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution. J Mol Biol. 1991;221:473–486
  21. Bao Y, Bolotov P, Dernovoy D, et al. The influenza virus resource at the National Center for Biotechnology Information. J Virol. 2008;82:596–601
  22. Kawakami C, Obuchi M, Saikusa M, et al. Isolation of oseltamivir-resistant influenza A/H1N1 virus of different origins in Yokohama City Japan, during the 2007–2008 influenza season. Jpn J Infect Dis. 2009;62:83–86
  23. Yasui K, Amano Y, Minami I, et al. Recent changes in the trends of seasonal influenza outbreaks in the Nagano Prefectural area of Japan: an oseltamivir effect?. J Infect Chemother. 2007;13:429–431
  24. The Infectious Diseases Surveillance Center. 2007/2008 influenza season, Japan. Infectious agents surveillance report 2008;29:297–9. Available at: http://idsc.nih.go.jp/iasr/29/345/tpc345.html. Accessed 3 August 2009.
  25. Jonges M, van der Lubben I, Dijkstra F, et al. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005–2008. Antiviral Res. 2009;83:290–297
  26. Dharan N, Gubareva L, Meyer J, et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA. 2009;301:1034–1041
  27. Kramarz P, Monnet D, Nicoll A, et al. Use of oseltamivir in 12 European countries between 2002 and 2007—lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses. Eur Surveill. 2009;14
  28. Gamblin S, Haire L, Russell R, et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science. 2004;303:1838–1842
  29. Saito R, Suzuki Y, Li D, et al. Increased incidence of adamantane-resistant influenza A(H1N1) and A(H3N2) viruses during the 2006–2007 influenza season in Japan. J Infect Dis. 2008;197:630–632;[author reply 2–3]
  30. Russell C, Jones T, Barr I, et al. The global circulation of seasonal influenza A (H3N2) viruses. Science. 2008;320:340–346
  31. WHO. Influenza A(H1N1) virus resistance to oseltamivir, 2008. Available at: http://www.who.int/csr/disease/influenza/ResistanceTable200806013.pdf. Accessed 27 July 2009.

PII: S1386-6532(09)00544-7

doi: 10.1016/j.jcv.2009.11.003

Journal of Clinical Virology
Volume 47, Issue 1 , Pages 23-28 , January 2010

Article Tools

* Image Usage & Resolution